We continue to make improvements in order to provide our customers with better solutions, even for high-difficulty challenges.
The candidates for the solid form of active pharmaceutical ingredients (APIs) are diverse, including free forms, salts, and co-crystals, each of which may have polymorphs. However, during the stage of narrowing down candidate compounds in drug development, it is necessary to select the solid form to be developed from these options. Generally, this process is referred to as solid form screening, but specific tasks are conducted according to the purpose, such as salt screening, co-crystal screening, and polymorph screening. In many cases, high-throughput (HT) screening systems are applied to these screenings. Our company continues to improve in order to provide better solutions for our customers, even for challenging issues such as poorly crystallizing compounds, compounds with undesirable properties, and compounds that do not crystallize, while also enhancing the efficiency of screening. *For more details, please refer to the related links. For further inquiries, feel free to contact us.*
Inquire About This Product
basic information
The detailed content of the column can be viewed through the related link. For more information, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the column through the related link. For more information, please feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.
